Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Cash from Operations (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed Cash from Operations for 6 consecutive years, with 10327000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 68.12% to 10327000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 48985000.0, a 50.63% increase, with the full-year FY2025 number at 48985000.0, up 50.63% from a year prior.
  • Cash from Operations was 10327000.0 for Q4 2025 at PROCEPT BioRobotics, down from 6635000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 6635000.0 in Q3 2025 to a low of 35928000.0 in Q1 2023.
  • A 5-year average of 19695850.0 and a median of 17678500.0 in 2022 define the central range for Cash from Operations.
  • Peak YoY movement for Cash from Operations: plummeted 97.07% in 2023, then soared 68.12% in 2025.
  • PROCEPT BioRobotics' Cash from Operations stood at 16476000.0 in 2021, then crashed by 52.79% to 25174000.0 in 2022, then increased by 1.51% to 24793000.0 in 2023, then plummeted by 30.65% to 32391000.0 in 2024, then skyrocketed by 68.12% to 10327000.0 in 2025.
  • Per Business Quant, the three most recent readings for PRCT's Cash from Operations are 10327000.0 (Q4 2025), 6635000.0 (Q3 2025), and 15043000.0 (Q2 2025).